Tandem Mass Spectrometry-Based Amyloid Typing Using Manual Microdissection and Open-Source Data Processing.


Journal

American journal of clinical pathology
ISSN: 1943-7722
Titre abrégé: Am J Clin Pathol
Pays: England
ID NLM: 0370470

Informations de publication

Date de publication:
04 05 2022
Historique:
received: 21 07 2021
accepted: 20 09 2021
entrez: 5 5 2022
pubmed: 6 5 2022
medline: 10 5 2022
Statut: ppublish

Résumé

Standard implementations of amyloid typing by liquid chromatography-tandem mass spectrometry use capabilities unavailable to most clinical laboratories. To improve accessibility of this testing, we explored easier approaches to tissue sampling and data processing. We validated a typing method using manual sampling in place of laser microdissection, pairing the technique with a semiquantitative measure of sampling adequacy. In addition, we created an open-source data processing workflow (Crux Pipeline) for clinical users. Cases of amyloidosis spanning the major types were distinguishable with 100% specificity using measurements of individual amyloidogenic proteins or in combination with the ratio of λ and κ constant regions. Crux Pipeline allowed for rapid, batched data processing, integrating the steps of peptide identification, statistical confidence estimation, and label-free protein quantification. Accurate mass spectrometry-based amyloid typing is possible without laser microdissection. To facilitate entry into solid tissue proteomics, newcomers can leverage manual sampling approaches in combination with Crux Pipeline and related tools.

Identifiants

pubmed: 35512256
pii: 6433227
doi: 10.1093/ajcp/aqab185
pmc: PMC9071319
doi:

Substances chimiques

Amyloid 0
Amyloidogenic Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

748-757

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM121818
Pays : United States

Informations de copyright

© American Society for Clinical Pathology, 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Nat Biotechnol. 2012 Oct;30(10):918-20
pubmed: 23051804
Haematologica. 2014 Jul;99(7):1239-47
pubmed: 24747948
J Histochem Cytochem. 2015 Oct;63(10):772-9
pubmed: 26101327
J Proteome Res. 2008 Jan;7(1):29-34
pubmed: 18067246
J Immunol. 1967 Aug;99(2):376-85
pubmed: 4166247
Mol Cell Proteomics. 2011 Sep;10(9):M111.011015
pubmed: 21642640
Kidney Int Rep. 2017 Aug 08;3(1):56-64
pubmed: 29340314
Anal Chem. 2013 Jun 4;85(11):5288-96
pubmed: 23590404
BMC Bioinformatics. 2012 Nov 19;13:308
pubmed: 23164367
J Am Soc Nephrol. 2018 Jan;29(1):231-239
pubmed: 29097624
Methods Mol Biol. 2013;931:213-57
pubmed: 23027006
Clin Chem. 2021 Jul 6;67(7):1008-1018
pubmed: 34136904
J Proteome Res. 2008 Jul;7(7):3022-7
pubmed: 18505281
Proteomics. 2013 Jan;13(1):22-4
pubmed: 23148064
J Cutan Pathol. 2004 Aug;31(7):465-70
pubmed: 15239675
Curr Opin Nephrol Hypertens. 2021 May 1;30(3):303-309
pubmed: 33395039
J Clin Pathol. 2015 Apr;68(4):314-7
pubmed: 25637636
Clin Proteomics. 2016 Oct 27;13:30
pubmed: 27795698
Am J Clin Pathol. 2001 Jul;116(1):135-42
pubmed: 11447744
J Mass Spectrom. 2013 Oct;48(10):1067-77
pubmed: 24130009
Blood Cancer J. 2018 May 23;8(5):44
pubmed: 29795248
Biomed Res Int. 2019 Jan 31;2019:3689091
pubmed: 30834260
Nat Methods. 2007 Nov;4(11):923-5
pubmed: 17952086
Kidney Int. 2019 Oct;96(4):1005-1009
pubmed: 31447055
Methods Mol Biol. 2016;1378:55-60
pubmed: 26602117
Front Immunol. 2018 Oct 16;9:2328
pubmed: 30459752
Nat Protoc. 2006;1(2):586-603
pubmed: 17406286
MethodsX. 2020 Jan 27;7:100770
pubmed: 32140436
N Engl J Med. 1965 Jul 15;273:143-6
pubmed: 14303661
Methods Enzymol. 2006;412:48-62
pubmed: 17046651
Annu Rev Pathol. 2017 Jan 24;12:277-304
pubmed: 27959636
J Proteome Res. 2014 Oct 3;13(10):4488-91
pubmed: 25182276
Lab Invest. 2008 Oct;88(10):1024-37
pubmed: 18711355
Curr Opin Biotechnol. 2000 Aug;11(4):391-5
pubmed: 10975459
Biochem Biophys Res Commun. 2009 Oct 16;388(2):256-60
pubmed: 19664600
Methods Mol Biol. 2013;1002:205-22
pubmed: 23625406

Auteurs

William S Phipps (WS)

Department of Laboratory Medicine and Pathology, Seattle, WA, USA.

Kelly D Smith (KD)

Department of Laboratory Medicine and Pathology, Seattle, WA, USA.
Department of Medicine, Seattle, WA, USA.

Han-Yin Yang (HY)

Department of Genome Sciences, University of Washington, Seattle, WA, USA.

Clark M Henderson (CM)

Department of Laboratory Medicine and Pathology, Seattle, WA, USA.
Seagen, Bothel, WA, USA.

Hannah Pflaum (H)

Department of Laboratory Medicine and Pathology, Seattle, WA, USA.
Seattle Children's Hospital, Seattle, WA, USA.

Melissa L Lerch (ML)

Department of Laboratory Medicine and Pathology, Seattle, WA, USA.

William E Fondrie (WE)

Department of Genome Sciences, University of Washington, Seattle, WA, USA.

Michelle A Emrick (MA)

Department of Laboratory Medicine and Pathology, Seattle, WA, USA.

Christine C Wu (CC)

Department of Genome Sciences, University of Washington, Seattle, WA, USA.

Michael J MacCoss (MJ)

Department of Genome Sciences, University of Washington, Seattle, WA, USA.

William S Noble (WS)

Department of Genome Sciences, University of Washington, Seattle, WA, USA.

Andrew N Hoofnagle (AN)

Department of Laboratory Medicine and Pathology, Seattle, WA, USA.
Department of Medicine, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH